Clover Health Investments, Corp. CLOV
4.49
(0.02)
(0.44%)
as of 25 Sep
- Market cap
- $2.5B
- P/E
- 0.0×
Follow CLOV
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (5.10%) | (16.86%) | (26.33%) | (17.08%) |
+8 more TTM periods Free account |
|
| (2.84%) | (8.89%) | (15.25%) | (9.62%) | ||
ROIC |
(8.62%) | (26.18%) | (28.37%) | (26.10%) | |
Return on Tangible Assets |
(10.84%) | (48.12%) | (81.15%) | (40.80%) | |
Average Days of Receivables |
10.78 | 12.13 | 17.99 | 11.92 | |
Free Cash Flow per Share |
0.14 | 0.10 | (0.13) | (0.17) | |
Free Cash Flow |
74.21 | 54.54 | (68.98) | (86.38) | |
Capital Expenditures |
(2.82) | (2.71) | (2.04) | (1.76) | |
Piotroski F-Score |
4.00 | 3.00 | 2.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
12.44% | 10.54% | (15.60%) | (15.56%) | |
Accounts Receivable Turnover |
41.27 | 34.82 | 26.29 | 32.18 | |
Accounts Payable Turnover |
58.16 | 51.77 | 44.32 | 47.64 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
6.41 | 7.92 | 8.43 | 8.60 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
19.23% | 20.88% | 22.85% | 24.34% | |
Share Based Compensation of Revenue |
2.92% | 4.05% | 5.39% | 6.11% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(4.20) | (1.01) | 0.78 | 1.45 | |
Depreciation/Fixed assets |
0.02 | (0.02) | (0.02) | (0.02) | |
Capex/Depreciation |
(20.32) | 24.21 | 13.01 | 15.18 | |
Revenue per Share |
4.72 | 4.23 | 3.76 | 3.46 | |
Operating CF per Share |
0.15 | 0.11 | (0.13) | (0.16) | |
Capex per Share |
(0.01) | (0.01) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(0.74%) | (2.58%) | (4.45%) | (3.29%) |
Columns are period end dates